Supports (Acquired resistant insufficiency syndrome or AIDS) is a sickness brought on by an infection called HIV (Human Immunodeficiency Virus). The sickness changes the invulnerable framework, making individuals substantially more defenseless to contaminations and infections. This helplessness exacerbates as the malady advances.
HIV is discovered in the form liquids of a contaminated individual (semen and vaginal liquids, blood and breast milk). The infection is passed starting with one individual then onto the next through blood-to-blood and sexual contact. What's more, spoiled pregnant ladies can pass HIV to their infants throughout pregnancy, conveying the child throughout labor, and through breast encouraging.
HIV might be transmitted from multiple points of view, for example vaginal, oral sex, butt-centric sex, blood transfusion, and sullied hypodermic needles.
Both the infection and the malady are frequently alluded to together as Hiv/aids. Individuals with HIV have what is called HIV tainting. Subsequently, some will then improve AIDS. The improvement of various pioneering contaminations in an AIDS patient can eventually prompt passing.
As per research, the sources of HIV go once again to the late nineteenth or early twentieth century in west-focal Africa. Supports and its reason, HIV, were initially distinguished and distinguished in the early 1980s.
There is as of now no cure for Hiv/aids. Medications can moderate the course of the illness -some spoiled individuals can carry on a long and moderately solid life.
Lipoatrophy - HIV, Diabetes
Tuesday, August 13, 2013
Saturday, December 4, 2010
Cosmetic Treatment Fillers
Here is a chart to view all the fillers used in cosmetic treatments and surgery's. This list is pretty complete but a lot of these are most likely outdated or not in use anymore. Visit this link to find more information. If your interested in the cosmetic treatment of Lipoatrophy http://www.clinicestetica.com/ was founded in 2001 to create seeking non-surgical permanent and semi-permanent solutions for cosmetic and reconstructive procedures, using a wide selection of products with proven safety and efficiency from around the world.
Product Name | Substance Type | Common Use | Claimed Effective Lifespan |
Achyal | Hyaluronic acid | Lips | Over 24 months |
Aquamid | Hhydrogel | Wrinkles, glabellar frowns, nasolabial folds, the depressed corners of the mouth, Lip augmentation | Over 24 months |
Artecoll | Round PMMA beads in a bovine collagen | Nasal labial folds, Lips, Wrinkles and scars | Over 24 months |
Bio-Alcamid | Poly-Alkyl-Imide | Facial defining and improving scars | Over 24 months |
Cymetra | Human tissue | lips, nasolabial folds, deep wrinkles and fine lines, as well as acne and depressed scars. | 3 to 6 months |
Dermalive | Irregular PMMA beads in hyaluronic acid | Lips and fine lines and wrinkles | Over 24 months |
Dermalive Deep | Irregular PMMA beads in hyaluronic acid | Nasal labial folds and deep wrinkles | Up to 12 months |
Evolence™ | Porcine (Pig) Collagen | Nasal labial folds, lips and other lines | Over 24 months |
Evolution | Polyacrylamide copolymer gel | Nasal labial folds, lips and other lines | 3 to 6 months |
Hylaform | Hyaluronic acid | Nasal labial folds, lines at the side of the mouth. | 3 to 6 months |
Hylaform Fineline | Hyaluronic acid | Nasal labial folds, lines at the side of the mouth. | 3 to 6 months |
Hylaform Plus | Hyaluronic acid | Deeper folds and lips | 3 to 6 months |
Newfill | Polylactic acid | fine lines, wrinkles and more marked furrows or creases | 18-24 months |
Outline | Polyacrylamide copolymer gel | Nasal labial folds, lips and other lines | 18months to 5 years |
Radiesse | CaHA microspheres | fine lines, wrinkles and more marked furrows or creases | 2 to 5 years |
Restylane Perlane | Non-animal, stabilised hyaluronic acid | Facial contours such as cheeks and chin. Deep folds. Volume lip augmentation. | 6-8 months |
Restylane | Non-animal, stabilised hyaluronic acid | Wrinkle correction Lip enhancements | 6-8 months |
Restylane Fine Lines | Non-animal, stabilised hyaluronic acid | Thin superficial lines around eyes, mouth, forehead & smile lines. | 6-8 months |
Sculptra | Polylactic acid | Nasal labial folds, corners of mouth,cheeks & chin, scars. | 18-24 months |
Surgiderm | Hyaluronic Acid | Nasal labial folds, corners of mouth,cheeks & chin, scars. | 18-24 months |
Zyderm 1 | Bovine collagen | Fine lines and wrinkles | 18-24 months |
Zyderm 2 | Bovine collagen | Fine lines and wrinkles | 1-4 months |
Zyplast | Bovine collagen | Deeper lines and lips | 1-4 months |
Tuesday, October 26, 2010
HIV Drug Combination Invirase Plus Norvir Can Cause Life Threatening Heart Problems
HIV antiviral medication Invirase (saquinavir) when taken in combination with Norvir (ritonavir), also an HIV antiviral, can increase the risk of life-threatening heart rhythm abnormalities, triggering the FDA (Food and Drug Administration) to announce the addition of new safety information to Invirase's labeling. Saquinivir is a protease inhibitor class medication which is marketed in two formulations, hard-ger capsule formulation of the mesylate (Invirase) - taken with ritonavir to increase saquiavir's bioavailability, and a soft-gel capsule (Fortovase).
In February of this year the FDA warned clinicians and patients that the drug combination could cause QT and PR interval prolongation (electrocardiogram heart rhythm activity indicators). QT interval refers to a measure (time) between the start of the Q wave and the end of the T wave in the heart's electrical cycle. The PR interval shows how long the electrical impulse takes to travel from the sinus node through the AV node and entering the ventricles (in the heart).
Patients with QT prolongation can develop torsades de pointes, a type of ventricular tachycardia that exhibits distinct characteristics on the electrocardiogram (abnormal heart rhythm). There is a higher risk of ventricular fibrillation, an irregular heart rhythm which can be fatal. Patients with torsades de pointes may experience lightheadedness or fainting.
PR interval prolongation can lead to heart block (or AV block), and the patient may experience lightheadedness, syncope (fainting), and palpitations. Heart block is an electrical fault in the heart.
The FDA announced that there will also be a medication guide for individuals taking Invirase; the guide will explain these possible risks. Patients with existing heart rate/rhythm problems, as well as those with underlying heart conditions are have a higher risk of developing one of the serious heart events described above.
Edward Cox, M.D., M.P.H, director, Office of Antimicrobial Products in FDA's Center for Drug Evaluation and Research, said:
Invirase, which is sometimes used with other medications for HIV treatment, apart from Norvir, was approved by the FDA in 1995.
In a communiqué, the FDA emphasizes that Invirase does not cure or prevent HIV infection, neither does it prevent the transmission of HIV infection to other people.
Invirase is manufactured and marketed by Genentech (part of Roche Group), San Francisco, California, and Norvir is manufactured and marketed by Abbot Laboratories, Abbot Park, Illinois.
In February of this year the FDA warned clinicians and patients that the drug combination could cause QT and PR interval prolongation (electrocardiogram heart rhythm activity indicators). QT interval refers to a measure (time) between the start of the Q wave and the end of the T wave in the heart's electrical cycle. The PR interval shows how long the electrical impulse takes to travel from the sinus node through the AV node and entering the ventricles (in the heart).
Patients with QT prolongation can develop torsades de pointes, a type of ventricular tachycardia that exhibits distinct characteristics on the electrocardiogram (abnormal heart rhythm). There is a higher risk of ventricular fibrillation, an irregular heart rhythm which can be fatal. Patients with torsades de pointes may experience lightheadedness or fainting.
PR interval prolongation can lead to heart block (or AV block), and the patient may experience lightheadedness, syncope (fainting), and palpitations. Heart block is an electrical fault in the heart.
The FDA announced that there will also be a medication guide for individuals taking Invirase; the guide will explain these possible risks. Patients with existing heart rate/rhythm problems, as well as those with underlying heart conditions are have a higher risk of developing one of the serious heart events described above.
Edward Cox, M.D., M.P.H, director, Office of Antimicrobial Products in FDA's Center for Drug Evaluation and Research, said:
"These heart conditions could potentially be life-threatening and we want to assure that health care providers and patients are adequately informed of the risks. Patients should talk to their doctor if they have any concerns about their treatment. Certain drugs may interact with Invirase and increase the risk of developing these side effects, so patients should be sure to tell their doctor about other medicines they may be taking, including non-prescription medicines, vitamins, and herbal supplements.Side effects from Invirase use experienced by patients or identified by clinicians should be reported to the FDA's MedWatch program.
Invirase, which is sometimes used with other medications for HIV treatment, apart from Norvir, was approved by the FDA in 1995.
In a communiqué, the FDA emphasizes that Invirase does not cure or prevent HIV infection, neither does it prevent the transmission of HIV infection to other people.
Invirase is manufactured and marketed by Genentech (part of Roche Group), San Francisco, California, and Norvir is manufactured and marketed by Abbot Laboratories, Abbot Park, Illinois.
Labels:
Cause,
Combination,
Heart,
Invirase,
Norvir,
Problems,
Threatening
Subscribe to:
Posts (Atom)